Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Automated And Rapid Microbiological Tests market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for Automated And Rapid Microbiological Tests are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Automated And Rapid Microbiological Tests market segmented into
Automated Identification & Susceptibility Systems
Automated Blood Culture Systems
Automated Tuberculosis Systems
Streptococcal Infection Rapid Tests
GC/Chlamydia Rapid Tests
Others
Based on the end-use, the global Automated And Rapid Microbiological Tests market classified into
Clinical
Non-Clinical
Based on geography, the global Automated And Rapid Microbiological Tests market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Abbott Laboratories
Abbott Diagnostics, Alere Inc.
Becton Dickinson and Company
bioMerieux SA, bioMerieux, Inc.
Bio-Rad Laboratories, Inc.
Cellabs Pty Ltd,
Celsis International Plc.
Coris BioConcept, F. Hoffmann-La Roche Ltd.
Gen-Probe Inc.
Genzyme Diagnostics
MedMira Inc.
Meridian Biosciences, Inc.
Orasure Technologies, Inc.
Orion Diagnostica Oy
Quidel Corporation
Siemens Healthcare Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
Remel, Inc.
Oxoid Limited
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL AUTOMATED AND RAPID MICROBIOLOGICAL TESTS INDUSTRY
2.1 Summary about Automated And Rapid Microbiological Tests Industry
2.2 Automated And Rapid Microbiological Tests Market Trends
2.2.1 Automated And Rapid Microbiological Tests Production & Consumption Trends
2.2.2 Automated And Rapid Microbiological Tests Demand Structure Trends
2.3 Automated And Rapid Microbiological Tests Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Automated Identification & Susceptibility Systems
4.2.2 Automated Blood Culture Systems
4.2.3 Automated Tuberculosis Systems
4.2.4 Streptococcal Infection Rapid Tests
4.2.5 GC/Chlamydia Rapid Tests
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Clinical
4.3.2 Non-Clinical
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Automated Identification & Susceptibility Systems
5.2.2 Automated Blood Culture Systems
5.2.3 Automated Tuberculosis Systems
5.2.4 Streptococcal Infection Rapid Tests
5.2.5 GC/Chlamydia Rapid Tests
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Clinical
5.3.2 Non-Clinical
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Automated Identification & Susceptibility Systems
6.2.2 Automated Blood Culture Systems
6.2.3 Automated Tuberculosis Systems
6.2.4 Streptococcal Infection Rapid Tests
6.2.5 GC/Chlamydia Rapid Tests
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Clinical
6.3.2 Non-Clinical
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Automated Identification & Susceptibility Systems
7.2.2 Automated Blood Culture Systems
7.2.3 Automated Tuberculosis Systems
7.2.4 Streptococcal Infection Rapid Tests
7.2.5 GC/Chlamydia Rapid Tests
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Clinical
7.3.2 Non-Clinical
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Automated Identification & Susceptibility Systems
8.2.2 Automated Blood Culture Systems
8.2.3 Automated Tuberculosis Systems
8.2.4 Streptococcal Infection Rapid Tests
8.2.5 GC/Chlamydia Rapid Tests
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Clinical
8.3.2 Non-Clinical
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Automated Identification & Susceptibility Systems
9.2.2 Automated Blood Culture Systems
9.2.3 Automated Tuberculosis Systems
9.2.4 Streptococcal Infection Rapid Tests
9.2.5 GC/Chlamydia Rapid Tests
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Clinical
9.3.2 Non-Clinical
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Abbott Laboratories
10.1.2 Abbott Diagnostics, Alere Inc.
10.1.3 Becton Dickinson and Company
10.1.4 bioMerieux SA, bioMerieux, Inc.
10.1.5 Bio-Rad Laboratories, Inc.
10.1.6 Cellabs Pty Ltd,
10.1.7 Celsis International Plc.
10.1.8 Coris BioConcept, F. Hoffmann-La Roche Ltd.
10.1.9 Gen-Probe Inc.
10.1.10 Genzyme Diagnostics
10.1.11 MedMira Inc.
10.1.12 Meridian Biosciences, Inc.
10.1.13 Orasure Technologies, Inc.
10.1.14 Orion Diagnostica Oy
10.1.15 Quidel Corporation
10.1.16 Siemens Healthcare Diagnostics, Inc.
10.1.17 Thermo Fisher Scientific, Inc.
10.1.18 Remel, Inc.
10.1.19 Oxoid Limited
10.2 Automated And Rapid Microbiological Tests Sales Date of Major Players (2017-2020e)
10.2.1 Abbott Laboratories
10.2.2 Abbott Diagnostics, Alere Inc.
10.2.3 Becton Dickinson and Company
10.2.4 bioMerieux SA, bioMerieux, Inc.
10.2.5 Bio-Rad Laboratories, Inc.
10.2.6 Cellabs Pty Ltd,
10.2.7 Celsis International Plc.
10.2.8 Coris BioConcept, F. Hoffmann-La Roche Ltd.
10.2.9 Gen-Probe Inc.
10.2.10 Genzyme Diagnostics
10.2.11 MedMira Inc.
10.2.12 Meridian Biosciences, Inc.
10.2.13 Orasure Technologies, Inc.
10.2.14 Orion Diagnostica Oy
10.2.15 Quidel Corporation
10.2.16 Siemens Healthcare Diagnostics, Inc.
10.2.17 Thermo Fisher Scientific, Inc.
10.2.18 Remel, Inc.
10.2.19 Oxoid Limited
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Table
1.Table Automated And Rapid Microbiological Tests Product Type Overview
2.Table Automated And Rapid Microbiological Tests Product Type Market Share List
3.Table Automated And Rapid Microbiological Tests Product Type of Major Players
4.Table Brief Introduction of Abbott Laboratories
5.Table Brief Introduction of Abbott Diagnostics, Alere Inc.
6.Table Brief Introduction of Becton Dickinson and Company
7.Table Brief Introduction of bioMerieux SA, bioMerieux, Inc.
8.Table Brief Introduction of Bio-Rad Laboratories, Inc.
9.Table Brief Introduction of Cellabs Pty Ltd,
10.Table Brief Introduction of Celsis International Plc.
11.Table Brief Introduction of Coris BioConcept, F. Hoffmann-La Roche Ltd.
12.Table Brief Introduction of Gen-Probe Inc.
13.Table Brief Introduction of Genzyme Diagnostics
14.Table Brief Introduction of MedMira Inc.
15.Table Brief Introduction of Meridian Biosciences, Inc.
16.Table Brief Introduction of Orasure Technologies, Inc.
17.Table Brief Introduction of Orion Diagnostica Oy
18.Table Brief Introduction of Quidel Corporation
19.Table Brief Introduction of Siemens Healthcare Diagnostics, Inc.
20.Table Brief Introduction of Thermo Fisher Scientific, Inc.
21.Table Brief Introduction of Remel, Inc.
22.Table Brief Introduction of Oxoid Limited
23.Table Products & Services of Abbott Laboratories
24.Table Products & Services of Abbott Diagnostics, Alere Inc.
25.Table Products & Services of Becton Dickinson and Company
26.Table Products & Services of bioMerieux SA, bioMerieux, Inc.
27.Table Products & Services of Bio-Rad Laboratories, Inc.
28.Table Products & Services of Cellabs Pty Ltd,
29.Table Products & Services of Celsis International Plc.
30.Table Products & Services of Coris BioConcept, F. Hoffmann-La Roche Ltd.
31.Table Products & Services of Gen-Probe Inc.
32.Table Products & Services of Genzyme Diagnostics
33.Table Products & Services of MedMira Inc.
34.Table Products & Services of Meridian Biosciences, Inc.
35.Table Products & Services of Orasure Technologies, Inc.
36.Table Products & Services of Orion Diagnostica Oy
37.Table Products & Services of Quidel Corporation
38.Table Products & Services of Siemens Healthcare Diagnostics, Inc.
39.Table Products & Services of Thermo Fisher Scientific, Inc.
40.Table Products & Services of Remel, Inc.
41.Table Products & Services of Oxoid Limited
42.Table Market Distribution of Major Players
43.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
44.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
45.Table Global Automated And Rapid Microbiological Tests Market Forecast (Million USD) by Region 2021f-2026f
46.Table Global Automated And Rapid Microbiological Tests Market Forecast (Million USD) Share by Region 2021f-2026f
47.Table Global Automated And Rapid Microbiological Tests Market Forecast (Million USD) by Demand 2021f-2026f
48.Table Global Automated And Rapid Microbiological Tests Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Automated And Rapid Microbiological Tests Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Automated And Rapid Microbiological Tests Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Automated And Rapid Microbiological Tests Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Automated And Rapid Microbiological Tests Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Automated And Rapid Microbiological Tests Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Automated And Rapid Microbiological Tests Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Automated And Rapid Microbiological Tests Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Automated Identification & Susceptibility Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Automated Blood Culture Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Automated Tuberculosis Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Streptococcal Infection Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure GC/Chlamydia Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Clinical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Non-Clinical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Automated Identification & Susceptibility Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Automated Blood Culture Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Automated Tuberculosis Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Streptococcal Infection Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure GC/Chlamydia Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Clinical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Non-Clinical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Automated Identification & Susceptibility Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Automated Blood Culture Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Automated Tuberculosis Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Streptococcal Infection Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure GC/Chlamydia Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Clinical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Non-Clinical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Automated Identification & Susceptibility Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Automated Blood Culture Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Automated Tuberculosis Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Streptococcal Infection Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure GC/Chlamydia Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Clinical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Non-Clinical Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Automated Identification & Susceptibility Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Automated Blood Culture Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Automated Tuberculosis Systems Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Streptococcal Infection Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure GC/Chlamydia Rapid Tests Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Clinical Segmentation Mark
Request Sample 
Request Discount 
Inquire Before Buy
